Continuation of statin treatment and mortality: a note of caution on excessive benefits

Arch Intern Med. 2009 Jun 8;169(11):1080; author reply 1080-1. doi: 10.1001/archinternmed.2009.157.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Aged
  • Cognition
  • Coronary Disease / drug therapy
  • Coronary Disease / mortality*
  • Coronary Disease / prevention & control
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Patient Compliance
  • Risk Reduction Behavior

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors